Who owns PMV Pharmaceuticals, Inc.?
Institutional ownership of PMVP from SEC Form 13F filings across 40 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
40
13F holders
$17.3M
value, 2026 filers
28.4%
of shares outstanding (15.2M sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of PMVP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Sio Capital Management, LLC | 2.6M | $3.5M | 0.6% | 4.9% | -14.4% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.4M | $3.2M | 0.0% | 4.4% | +26.9% |
| 3 | ACADIAN ASSET MANAGEMENT LLC | 2.2M | $2,968 | 0.0% | 4.2% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $2.7M | 0.0% | 3.8% | -49.1% |
| 5 | TWO SIGMA INVESTMENTS, LP | 2.0M | $2.6M | 0.0% | 3.7% | +3.7% |
| 6 | BlackRock, Inc. | 919,818 | $1.2M | 0.0% | 1.7% | +5.2% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 473,158 | $634,624 | 0.0% | 0.9% | -4.6% |
| 8 | Walleye Capital LLC | 335,694 | $449,830 | 0.0% | 0.6% | -50.0% |
| 9 | Assenagon Asset Management S.A. | 330,003 | $442,204 | 0.0% | 0.6% | -8.5% |
| 10 | MARSHALL WACE, LLP | 321,610 | $430,956 | 0.0% | 0.6% | -25.9% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 254,775 | $341,399 | 0.0% | 0.5% | -14.5% |
| 12 | BANK OF AMERICA CORP /DE/ | 240,110 | $321,747 | 0.0% | 0.5% | -0.2% |
| 13 | RBF Capital, LLC | 162,200 | $217,348 | 0.0% | 0.3% | -50.0% |
| 14 | GOLDMAN SACHS GROUP INC | 136,994 | $183,572 | 0.0% | 0.3% | +19.3% |
| 15 | MAI Capital ManagementNEW | 133,122 | $178,383 | 0.0% | 0.2% | new |
| 16 | NORTHERN TRUST CORP | 93,047 | $124,683 | 0.0% | 0.2% | -19.4% |
| 17 | PNC Financial Services Group, Inc. | 67,938 | $91,038 | 0.0% | 0.1% | -0.5% |
| 18 | HRT FINANCIAL LPNEW | 50,510 | $67 | 0.0% | 0.1% | new |
| 19 | Accurate Wealth Management, LLC | 50,000 | $62,000 | 0.0% | 0.1% | 0.0% |
| 20 | CITADEL ADVISORS LLC | 47,308 | $63,393 | 0.0% | 0.1% | +5.0% |
| 21 | MORGAN STANLEY | 41,684 | $55,856 | 0.0% | 0.1% | -95.2% |
| 22 | JANE STREET GROUP, LLC | 40,207 | $53,878 | 0.0% | 0.1% | -67.6% |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 37,531 | $50,292 | 0.0% | 0.1% | new |
| 24 | Connor, Clark & Lunn Investment Management Ltd. | 32,460 | $43,496 | 0.0% | 0.1% | 0.0% |
| 25 | Squarepoint Ops LLC | 31,833 | $42,656 | 0.0% | 0.1% | +16.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.